NasdaqGM:CERSMedical Equipment
Cerus (CERS) Stock Sinks As Margin Pressure Deepens Despite Revenue Growth
Cerus stock just absorbed a hit, sliding about 26% to US$2.15 after its latest earnings, even though the company reported another quarter of double digit product revenue growth and nudged full year guidance higher. The headline is not a collapse in demand. The headline is a profit story that still sits in the red and a margin profile under pressure, with product gross margin at 51.4%. For short term traders the selloff is the story. For longer term investors the key question is how that...